Use of Angiotensin Converting Enzyme Inhibitors and Risk of Late Bladder Toxicity Following Radiotherapy for Prostate Cancer

被引：0
|
作者：
Kerns, S. L. [1 ]
Morlang, A. [1 ]
Lee, S. M. [2 ]
Hall, W. A. [3 ]
Peterson, D. [4 ]
Marples, B. [1 ]
Zhang, H. [1 ]
Bylund, K. C. [1 ]
Rosenzweig, D. [1 ]
de Ruyck, K. [5 ]
Rosenstein, B. S. [6 ]
Gomez CaamaNo, A. [7 ]
Vega, A. [8 ]
Parker, C. [9 ,10 ]
West, C. M. L. [11 ]
Janelsins, M. [12 ]
Chen, Y. [1 ]
Messing, E. [13 ]
Morrow, G. [12 ]
机构：
[1] Univ Rochester, Dept Radiat Oncol, Rochester, NY USA
[2] Univ Rochester, Rochester, NY USA
[3] Med Coll Wisconsin, Dept Radiat Oncol, Milwaukee, WI 53226 USA
[4] Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY USA
[5] Univ Ghent, Ghent, Belgium
[6] Icahn Sch Med Mt Sinai, Dept Radiat Oncol, New York, NY USA
[7] H Clin Univ, Santiago De Compostela, Spain
[8] Univ Santiago de Compostela, Santiago De Compostela, Spain
[9] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England
[10] Inst Canc Res, Sutton, Surrey, England
[11] Univ Manchester, Manchester, Lancs, England
[12] Univ Rochester, Dept Surg, Canc Control, Rochester, NY USA
[13] Univ Rochester, Med Ctr, Dept Urol, Rochester, NY 14642 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2566
引用
收藏
页码：E280 / E281
页数：2
相关论文
共 50 条
  • [1] Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer
    Kerns, Sarah L.
    Morlang, Ashley Amidon
    Lee, Sharon M.
    Peterson, Derick R.
    Marples, Brian
    Zhang, Hong
    Bylund, Kevin
    Rosenzweig, Doug
    Hall, William
    De Ruyck, Kim
    Rosenstein, Barry S.
    Stock, Richard G.
    Gomez-Caamano, Antonio
    Vega, Ana
    Sosa-Fajardo, Paloma
    Taboada-Valladares, Begona
    Aguado-Barrera, Miguel E.
    Parker, Chris
    Veldeman, Liv
    Fonteyne, Valerie
    Bultijnck, Renee
    Talbot, Christopher J.
    Symonds, R. Paul
    Johnson, Kerstie
    Rattay, Tim
    Webb, Adam
    Lambrecht, Maarten
    de Ruysscher, Dirk
    Vanneste, Ben
    Choudhury, Ananya
    Elliott, Rebecca M.
    Sperk, Elena
    Herskind, Carsten
    Veldwijk, Marlon R.
    Rancati, Tiziana
    Avuzzi, Barbara
    Valdagni, Riccardo
    Azria, David
    Farcy Jacquet, Marie-Pierre
    Chang-Claude, Jenny
    Seibold, Petra
    West, Catharine
    Janelsins, Michelle
    Chen, Yuhchyau
    Messing, Edward
    Morrow, Gary
    Azria, David
    Briers, Erik
    Chang-Claude, Jenny
    Choudhury, Ananya
    RADIOTHERAPY AND ONCOLOGY, 2022, 168 : 75 - 82
  • [2] Exploring the Role of Angiotensin Converting Enzyme Inhibitors in Genito-Urinary Toxicity Following Curative Radiotherapy for Bladder Cancer
    Devi, A.
    Olowofela, A.
    Lodhi, T.
    Hoskin, P.
    Ballas, L. K.
    Choudhury, A.
    Kerns, S. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E524 - E524
  • [3] The Incidence and Risk of Biochemical Recurrence Following Radical Radiotherapy for Prostate Cancer in Men on Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin Receptor Blockers (ARBs)
    Alashkham, Abduelmenem
    Paterson, Catherine
    Windsor, Phyllis
    Struthers, Allan
    Rauchhaus, Petra
    Nabi, Ghulam
    CLINICAL GENITOURINARY CANCER, 2016, 14 (05) : 398 - 405
  • [4] THE INCIDENCE AND RISK OF BIOCHEMICAL RECURRENCE FOLLOWING RADICAL RADIOTHERAPY FOR PROSTATE CANCER IN MEN ON ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACEIS) OR ANGIOTENSIN RECEPTOR BLOCKERS (ARB)
    Alashkham, Abduelmenem
    Paterson, Catherine
    Windsor, Phyllis
    Struthers, Allan
    Rauchhaus, Petra
    Nabi, Ghulam
    JOURNAL OF UROLOGY, 2016, 195 (04): : E676 - E676
  • [5] Angiotensin converting enzyme inhibitors and the risk of lung cancer
    Hicks, Blanaid
    Filion, Kristan B.
    Yin, Hui
    Sakr, Lama
    Udell, Jacob A.
    Azoulay, Laurent
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 463 - 463
  • [6] Inhibitors of angiotensin-I-converting enzyme and risk of cancer
    Sattar, N
    McMillan, DC
    LANCET, 1998, 352 (9134): : 1151 - 1151
  • [7] Angiotensin converting enzyme (ACE) inhibitors: impact on men receiving primary radiotherapy (RT) for prostate cancer (PC)
    Ranasinghe, Weranja
    Williams, Scott
    Sengupta, Shomik
    Chang, Mike
    Shulkes, Arthur
    Bolton, Damien M.
    Baldwin, Graham
    Patel, Oneel
    BJU INTERNATIONAL, 2013, 112 : 20 - 20
  • [8] Late toxicity rates following definitive radiotherapy for prostate cancer
    Ohri, Nitin
    Dicker, Adam P.
    Showalter, Timothy N.
    CANADIAN JOURNAL OF UROLOGY, 2012, 19 (04) : 6373 - 6380
  • [9] Angiotensin converting enzyme inhibitors for cancer treatment?
    Lindberg, H
    Nielsen, D
    Jensen, BV
    Eriksen, J
    Skovsgaard, T
    ACTA ONCOLOGICA, 2004, 43 (02) : 142 - 152
  • [10] Plasma TGFβ1 as a predictor of late bladder or rectal toxicity following radiotherapy in patients with prostate cancer
    Elconin, JH
    Kong, F
    Jirtle, RL
    Clough, RW
    Anscher, MS
    RADIOLOGY, 1998, 209P : 287 - 287
12345